Carol Gail Ashe - Net Worth and Insider Trading

Carol Gail Ashe Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Carol Gail Ashe owns 2 companies in total, including Aptose Biosciences Inc (APTO) , and Elicio Therapeutics Inc (ELTX) .

Click here to see the complete history of Carol Gail Ashe’s form 4 insider trades.

Insider Ownership Summary of Carol Gail Ashe

Ticker	Comapny	Transaction Date	Type of Owner
APTO	Aptose Biosciences Inc	2018-12-21	director
ELTX	Elicio Therapeutics Inc	2023-06-01	director

Carol Gail Ashe Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Carol Gail Ashe Ownership Network

Ownership Network List of Carol Gail Ashe

No Data

Ownership Network Relation of Carol Gail Ashe

Carol Gail Ashe Owned Company Details

What does Aptose Biosciences Inc do?

Who are the key executives at Aptose Biosciences Inc?

Carol Gail Ashe is the director of Aptose Biosciences Inc. Other key executives at Aptose Biosciences Inc include director & Chair & President & CEO William G. Rice , SR VP & Chief Fin. Officer Fletcher Payne , and Chief Commercial Officer Philippe Ledru .

Aptose Biosciences Inc (APTO) Insider Trades Summary

Over the past 18 months, Carol Gail Ashe made no insider transaction in Aptose Biosciences Inc (APTO). Other recent insider transactions involving Aptose Biosciences Inc (APTO) include a net purchase of 17,000 shares made by Bernd R. Seizinger ,

In summary, during the past 3 months, insiders sold 0 shares of Aptose Biosciences Inc (APTO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aptose Biosciences Inc (APTO) were sold and 17,000 shares were bought by its insiders, resulting in a net purchase of 17,000 shares.

Aptose Biosciences Inc (APTO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aptose Biosciences Inc Insider Transactions

No Available Data

Carol Gail Ashe Mailing Address

Above is the net worth, insider trading, and ownership report for Carol Gail Ashe. You might contact Carol Gail Ashe via mailing address: C/o Aptose Biosciences Inc., 251 Consumers Road, Suite 1105, Toronto A6 M2j 4r3.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.